Compound 1032
Identifiers
- Canonical SMILES:
CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)N2CCCC[C@@H]2C(O)=O)c(Cl)c1Cl
- IUPAC name:
1-[2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]cyclopropanecarbonyl]piperidine-2-carboxylic acid
- InChi:
InChI=1S/C25H27Cl2NO3S/c1-14(2)15-7-3-4-9-20(15)32-21-11-10-16(22(26)23(21)27)17-13-18(17)24(29)28-12-6-5-8-19(28)25(30)31/h3-4,7,9-11,14,17-19H,5-6,8,12-13H2,1-2H3,(H,30,31)/t17-,18+,19+/m0/s1
- InChiKey:
LBFPLUWTLKUUCU-IPMKNSEASA-N
External links
168318101 |
19174412 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 7.89 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 491.11 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 6.80 | |||
TPSA | 57.61 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5482 | Ramiprilat | DB14208 | |
0.5482 | Trandolaprilat | DB14209 | |
0.5448 | Lisinopril | DB00722 | |
0.5263 | Enalaprilat | DB09477 | |
0.5137 | Ramipril | DB00178 | |
0.5137 | Trandolapril | DB00519 | |
0.5130 | RB106 | DB02669 | |
0.5076 | Ubenimex | DB03424 | |
0.5072 | Ethylaminobenzylmethylcarbonyl Group | DB03090 | |
0.5000 | Kelatorphan | DB08040 | |
0.5000 | Tedatioxetine | DB12641 | |
0.4962 | Nateglinide | DB00731 | |
0.4931 | Enalapril | DB00584 | |
0.4815 | NS-2359 | DB05805 | |
0.4815 | Metixene | DB00340 |